cbdMD, Inc.
YCBDNYSE
$0.57
↓ -7.6%Jul 17 close · end-of-day
Price
1Y↓ -38.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$20.0M
Net Income (TTM)
-$2.7M
Free Cash Flow (TTM)
-$2.7M
Gross Margin
59.4%
Operating Margin
-13.4%
Net Margin
-13.3%
ROE
-28.6%
ROIC
-31.8%
Debt / Equity
—
Net Cash
$2.6M
Return 1Y
-38.5%
Company profile
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. Its products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It has a research partnership with the University of Mississippi to identify novel cannabinoids.
- CEO
- Martin A. Sumichrast
- Sector
- Manufacturing
- Industry
- Consumer Goods
- Employees
- 90
- Headquarters
- North Carolina
- Website
- cbdmd.com
Earnings
YCBD Q2 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.6M↑ +18.8%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $41.9M | $44.5M | $35.4M | $24.2M | $19.5M | $19.2M |
| Gross profit | $26.4M | $30.0M | $22.3M | $15.0M | $12.0M | $12.0M |
| Operating income | -$17.6M | -$19.6M | -$78.3M | -$22.5M | -$3.3M | -$2.2M |
| Net income | $12.6M | -$23.4M | -$70.1M | -$22.9M | -$3.7M | -$2.0M |
| Diluted EPS | $0.28 | -$0.47 | -$55.80 | -$13.32 | -$14.29 | -$1.09 |
| Operating cash flow | -$10.7M | -$14.1M | -$15.0M | -$4.3M | -$352,792.00 | -$1.5M |
| Free cash flow | — | -$14.4M | -$15.7M | -$4.6M | -$542,807.00 | -$1.6M |
| Gross margin | 63.0% | 67.4% | 63.1% | 62.0% | 61.6% | 62.4% |
| Operating margin | -42.0% | -44.1% | -221.1% | -93.1% | -17.0% | -11.3% |
| Net margin | 30.1% | -52.6% | -198.0% | -95.0% | -19.0% | -10.6% |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2M | $4.6M | $5.1M | $4.7M | $4.6M | $4.7M | $5.0M | $5.6M |
| Gross profit | $3.4M | $2.5M | $3.4M | $3.0M | $2.8M | $2.8M | $3.0M | $3.3M |
| Operating income | -$382,028.00 | -$316,556.00 | -$86,272.00 | -$485,816.00 | -$904,686.00 | -$685,816.00 | -$286,288.00 | -$800,784.00 |
| Net income | $459,737.00 | -$152,798.00 | $15,095.00 | -$480,757.00 | -$895,272.00 | -$679,968.00 | -$283,131.00 | -$797,978.00 |
| Diluted EPS | -$0.15 | — | — | — | — | — | — | — |
| Operating cash flow | $289,779.00 | $167,377.00 | -$317,949.00 | -$189,477.00 | -$704,200.00 | -$240,749.00 | -$812,464.00 | -$722,500.00 |
| Free cash flow | $289,779.00 | $157,377.00 | -$482,336.00 | -$204,983.00 | -$705,675.00 | -$243,553.00 | -$977,266.00 | -$728,248.00 |
| Gross margin | 65.8% | 53.9% | 66.5% | 62.3% | 61.5% | 58.8% | 59.8% | 57.7% |
| Operating margin | -7.4% | -6.9% | -1.7% | -10.2% | -19.6% | -14.5% | -5.7% | -14.2% |
| Net margin | 8.9% | -3.4% | 0.3% | -10.1% | -19.4% | -14.4% | -5.6% | -14.1% |
Company news
Jul 14, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.